首页 | 本学科首页   官方微博 | 高级检索  
     


High‐frequency vibration for the recanalization of guidewire refractory chronic total coronary occlusions
Authors:Klaus Tiroch MD  Louis Cannon MD  Mark Reisman MD  Ronald Caputo MD  Todd Caulfield MD  Richard Heuser MD  Greg Braden MD  Reginald Low MD  Gregg Stone MD  Alexandra Almonacid MD  Jeffrey J. Popma MD
Affiliation:1. Cardiovascular Division, Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts;2. Cardiovascular Division, Department of Internal Medicine, Northern Michigan Hospital, Petoskey, Michigan;3. Cardiovascular Division, Department of Internal Medicine, Swedish Medical Center, Seattle, Washington;4. Cardiovascular Division, Department of Internal Medicine, St. Joseph Medical Center, Syracuse, New York;5. Cardiovascular Division, Department of Internal Medicine, Providence St. Vincent's Medical Center, Portland, Oregon;6. Cardiovascular Division, Department of Internal Medicine, St. Joseph's Hospital of Phoenix, Phoenix, Arizona;7. Cardiovascular Division, Department of Internal Medicine, Forsyth Medical Center, Winston‐Salem, North Carolina;8. Cardiovascular Division, Department of Internal Medicine, University of California Davis Medical Center, Davis, California;9. Cardiovascular Division, Department of Internal Medicine, Columbia University Medical Center, New York, New York;10. Cardiovascular Division, Department of Internal Medicine, St. Elizabeth Medical Center, Boston, Massachusetts
Abstract:Background: Recanalization of coronary chronic total occlusions (CTOs) remains a clinical challenge, particularly when standard guidewire attempts fail. Objectives: We sought to determine the safety and efficacy of a novel method that used high‐frequency (20 kHz) vibration to fragment occlusive fibrous tissue and facilitate guidewire crossing into the distal vessel. Methods: A total of 125 patients with CTO, who failed at attempts of conventional guidewire recanalization after more than 5 min of fluoroscopy time, were enrolled in the study. The primary efficacy endpoint was the advancement of the CROSSER? catheter through the occlusion and attainment of coronary guidewire positioning in the distal coronary lumen. The primary safety endpoint was the occurrence of death, myocardial infarction, clinical perforation, or target vessel revascularization within the first 30 days. Results: The average fluoroscopy time while delivering the CROSSER catheter was 12.4 min. CROSSER‐assisted guidewire recanalization was achieved in 76 (60.8%) procedures and a final diameter stenosis <50% was obtained in 68 (54.4%) of cases. Major adverse events occurred in 11 (8.8%) patients, lower than the predefined objective performance criteria. Angina frequency and quality of life were improved in patients with successful guidewire recanalization. Conclusions: We conclude that high‐frequency vibration using the CROSSER catheter is a safe and effective therapy for patients with CTO, which are refractory to standard guidewire recanalization. © 2008 Wiley‐Liss, Inc.
Keywords:chronic total occlusion  coronary stents  recanalization device  coronary artery disease
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号